• Table of Contents

    Jan 1, 2018, 00:00

  • Cost-Effectiveness and Value of Information Analysis of Brief Interventions to Promote Physical Activity in Primary Care

    Jan 1, 2018, 00:00

  • Payer and Pharmaceutical Manufacturer Considerations for Outcomes-Based Agreements in the United States

    Jan 1, 2018, 00:00

  • Editorial Board

    Jan 1, 2018, 00:00

  • Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis- An Indirect Comparison Using Individual Patient Data from Randomized Trials

    Jan 1, 2018, 00:00

  • Instructions for Authors

    Jan 1, 2018, 00:00

  • Using a Discrete-Choice Experiment Involving Cost to Value a Classification System Measuring the Quality-of-Life Impact of Self-Management for Diabetes

    Jan 1, 2018, 00:00

  • Women’s Benefits and Harms Trade-Offs in Breast Cancer Screening- Results from a Discrete-Choice Experiment

    Jan 1, 2018, 00:00

  • The Burden of Peristomal Skin Complications on an Ostomy Population as Assessed by Health Utility and the Physical Component Summary of the SF-36v2

    Jan 1, 2018, 00:00

  • Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Codes Are Not Available- A Validation Study Comparing Medication/Prescriber Visit–Based Algorithms with Diagnosis Codes

    Jan 1, 2018, 00:00

  • An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds

    Jan 1, 2018, 00:00

  • Standards for Instrument Migration When Implementing Paper Patient-Reported Outcome Instruments Electronically- Recommendations from a Qualitative Synthesis of Cognitive Interview and Usability Studies

    Jan 1, 2018, 00:00

  • EQ-5D- Moving from Three Levels to Five

    Jan 1, 2018, 00:00

  • EQ-5D-5L versus EQ-5D-3L- The Impact on Cost Effectiveness in the United Kingdom

    Jan 1, 2018, 00:00

  • Trading Bankruptcy for Health- A Discrete-Choice Experiment

    Jan 1, 2018, 00:00

  • Letter to the Editor- Emerging Guidelines for Patient Engagement in Research

    Dec 1, 2017, 00:00

  • Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions- An Illustration for Metastatic Castration-Resistant Prostate Cancer

    Dec 1, 2017, 00:00

  • Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease

    Dec 1, 2017, 00:00

  • An Exploratory Study on Using Principal-Component Analysis and Confirmatory Factor Analysis to Identify Bolt-On Dimensions- The EQ-5D Case Study

    Dec 1, 2017, 00:00

  • Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands- A Country Adaptation Analysis Under the Former and Current Du ...

    Dec 1, 2017, 00:00

  • Scientific Evidence in Health Technology Assessment Reports- An In-Depth Analysis of European Assessments on High-Risk Medical Devices

    Dec 1, 2017, 00:00

  • Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure- A Network Meta-Analysis

    Dec 1, 2017, 00:00

  • Table of Contents

    Dec 1, 2017, 00:00

  • Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer

    Dec 1, 2017, 00:00

  • The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies- Findings from the INITIATOR Study

    Dec 1, 2017, 00:00

  • ISPOR Code of Ethics 2017 (4th Edition)

    Dec 1, 2017, 00:00

  • Copyright/Subscription

    Dec 1, 2017, 00:00

  • Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer- The OPTIMA Prelim Trial

    Dec 1, 2017, 00:00

  • A (Latent) Class of Their Own- Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises

    Dec 1, 2017, 00:00

  • Value of Implementation of Strategies to Increase the Adherence of Health Professionals and Cancer Survivors to Guideline-Based Physical Exercise

    Dec 1, 2017, 00:00

  • Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus- A Cost-Utility Analysis

    Dec 1, 2017, 00:00

  • Editorial Board

    Dec 1, 2017, 00:00

  • Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit

    Dec 1, 2017, 00:00

  • Nephrectomy Complication Is a Risk Factor of Clinically Meaningful Decrease in Health Utility among Living Kidney Donors

    Dec 1, 2017, 00:00

  • Author Response- Patient Engagement

    Dec 1, 2017, 00:00

  • Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial- An Update with Empirical Trial–Based Cost Data

    Dec 1, 2017, 00:00

  • Development and Validation of the AFImpact- An Atrial Fibrillation–Specific Measure of Patient-Reported Health-Related Quality of Life

    Dec 1, 2017, 00:00

  • Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation- A Multicriteria Decision Analysis

    Dec 1, 2017, 00:00

  • Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation

    Dec 1, 2017, 00:00

  • Comparing Methods for Estimating Direct Costs of Adverse Drug Events

    Dec 1, 2017, 00:00

  • Next Edition of the ISPOR Code of Ethics- Is It Setting Us up for the Era of Digitized Health Care?

    Dec 1, 2017, 00:00

  • Reviewer Acknowledgement 20/10

    Dec 1, 2017, 00:00

  • Health Care System

    Dec 1, 2017, 00:00

  • The Role of Noncomparative Evidence in Health Technology Assessment Decisions

    Dec 1, 2017, 00:00

  • Value and Impact of Incorporating Uncertainty into Opinion Based Research- Study on American College of Medical Genetics (ACMG) Recommendations for Newborn Screening (NBS) for Cystic Fibrosis (CF)

    Oct 1, 2017, 00:00

  • Estimating The Drug Treatment Cost of Breast Cancer

    Oct 1, 2017, 00:00

  • When And Where To Use Furigana? The Application Of Phonetic Notation In Japanese Translations Of Clinical Outcomes Assessments (COAS) For Children

    Oct 1, 2017, 00:00

  • The Impact Of Human Papillomavirus Vaccine In Taiwan- A Transmission Dynamic Modelling Approach

    Oct 1, 2017, 00:00

  • Adherence Patterns Among Patients Using Oral Atypical Antipsychotics and Other Medications

    Oct 1, 2017, 00:00

  • Time To Market Access For Oncology Medicines In Gree Has It Changed During The Crisis?

    Oct 1, 2017, 00:00

  • Costs and Benefits of Implementing Non-Invasive Prenatal Testing For Trisomy 21 (T21) Based on Cell Free DNA (CFDNA) Sequencing In Maternal Plasma In France

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Afatinib Versus Gefitinib in Egfr-Mutated Population with Advanced Non-Small-Cell Lung Cancer in France

    Oct 1, 2017, 00:00

  • Patient Insights In Copd Medication Adherence From Pharmacy Data

    Oct 1, 2017, 00:00

  • Longitudinal Study into the Dispensing Patterns of Benzodiazepines and Z-Drugs in a South African Private Healthcare Setting

    Oct 1, 2017, 00:00

  • The Presentation Of Patients With Epistaxis Shows A Marked Seasonal Variation In Germany

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Edoxaban In Patients With Non-Valvular Atrial Fibrillation In Hong Kong

    Oct 1, 2017, 00:00

  • Willingness-To-Pay For Life-Saving Treatments In Thailand- A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Social And Financial Impact Of Dravet Syndrome

    Oct 1, 2017, 00:00

  • Identification Of Important Criteria For Drug Reimbursement Decision-Making And Their Relative Importance

    Oct 1, 2017, 00:00

  • Dispute Issues About The Healing And Health Promotion Of Children

    Oct 1, 2017, 00:00

  • Modelling Patient Pathways Of Low-Dose Computed Tomography Screening For Lung Cancer In Hungary

    Oct 1, 2017, 00:00

  • Pharmacoepidemiological Survey Of Under- Five Antidiarrhea Drugs Utilization In A Tertiary Teaching Hospital In Enugu Metropolis Southeast Nigeria

    Oct 1, 2017, 00:00

  • Evaluating Endpoints and Changing Trends In Advanced Stages of Cancer Related Clinical Trials

    Oct 1, 2017, 00:00

  • Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke

    Oct 1, 2017, 00:00

  • The Utilisation Of Biosimilar Infliximab By English Acute Trusts

    Oct 1, 2017, 00:00

  • Decision Analytic Modelling Methods For The Assessing The Effectiveness Of Treatment Sequences For Clinical And Economic Decision Making- A Methodological Review

    Oct 1, 2017, 00:00

  • Determining The Value of Selexipag For The Treatment of Pulmonary Arterial Hypertension (PAH) In Spain By Multi-Criteria Decision Analysis (MCDA)

    Oct 1, 2017, 00:00

  • Intensity Modulated Radiation Therapy In Malignant Pleural Mesothelioma; A Piolt For Treatment Outcomes And Cost-Effective Expectations

    Oct 1, 2017, 00:00

  • Análisis Comparativo De Costos Entre Trastuzumab Para Administración Subcutánea En Comparación Con La Formulación Para Administración Intravenosa Desde La Perspectiva De La Seguridad Social Costarricense

    Oct 1, 2017, 00:00

  • Maximum Difference Scaling To Enhance Insight In Qualitative Payer Research

    Oct 1, 2017, 00:00

  • Intermediate Evaluation of Vivoptim- The Mgen (French Insurer) Prevention Program for Cardiovascular Risks

    Oct 1, 2017, 00:00

  • Market Access of Nintedanib for Idiopathic Pulmonary Fibrosis- A Cross-Country Review of Access Conditions

    Oct 1, 2017, 00:00

  • Real-World Data Analysis of Cancer Treatment Cost Drivers By Type and Place of Service

    Oct 1, 2017, 00:00

  • Retrospective Analysis of Patients Treated with Computer-Assisted External Ring Fixators- A Descriptive Analysis of Patient Demographics, Healthcare Untilization, And Costs In The U.S

    Oct 1, 2017, 00:00

  • Systematic Review On Economic Impact Of Air Pollution On Health

    Oct 1, 2017, 00:00

  • Economic Burden of Autism and Autism-Related Spectrum Disorders (Asd) In EU5 Countries

    Oct 1, 2017, 00:00

  • Cost and Effectiveness of the use of Sorafenib in Differentiated Thyroid Cancer

    Oct 1, 2017, 00:00

  • Assessing Uptake Of Medicine Use Reviews In English Community Pharmacies

    Oct 1, 2017, 00:00

  • The Analysis Of New Drug Reimbursement Decision Making In South Korea After The Introduction Of Positive Listing System

    Oct 1, 2017, 00:00

  • Quality of Life And Utility Decrement Associated With Clostridium Difficile Infection In French Acute Care Facilities

    Oct 1, 2017, 00:00

  • Characterization And Approximation Of The Direct Costs Of Axial And Peripheral Spondyloarthritis In A Clinical Management Center In Colombia

    Oct 1, 2017, 00:00

  • Characteristics Of The Dietary Habits Of Cancer Patients And Structure Of Consumption Of Basic Food Products

    Oct 1, 2017, 00:00

  • Economic Evaluation Of A Brief Counselling For Smoking Cessation In Dentistry – A Case Study Comparing Two Health Economic Models

    Oct 1, 2017, 00:00

  • Defining Criteria Weights By AHP In Health Technology Assessment

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Pulmonary Embolism In Europe – Mortality And Health Related Quality Of Life

    Oct 1, 2017, 00:00

  • Evaluating The Use of Central Nervous System Stimulants Among Medical and Non-Medical Students

    Oct 1, 2017, 00:00

  • Evolution of The Time-To-Market of Hospital Products In Spain

    Oct 1, 2017, 00:00

  • Advanced Monte-Carlo Sampling Schemes for Value of Information Estimation

    Oct 1, 2017, 00:00

  • Secondary Care Resource Utilization And Cost Of Care Among Finnish Inflammatory Bowel Disease Patients

    Oct 1, 2017, 00:00

  • Blood Pressure Measuring Techniques, Examination of The Blood Pressure Values In Relation With The Operating Principle of The Device

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Modeling Evaluation Comparing Originator Follitropin Alfa To A Biosimilar For The Treatment of Infertility In Germany, Italy And Spain

    Oct 1, 2017, 00:00

  • Descalonamento Da Terapia Antimicrobiana- Uma Estratégia De Racionalização E Custo-Minimização Em Cenário Privado De Saúde No Ceará

    Oct 1, 2017, 00:00

  • Impact of Metabolic Surgery on Cost and Long-Term Health Outcome- A Cost-Effectiveness Approach

    Oct 1, 2017, 00:00

  • Venous Thromboembolism Prophylaxis- Risk Assessment Compliance with Respected Patient Risk

    Oct 1, 2017, 00:00

  • Real World Evidence in Glaucomatous Diseases- Emr Data is Indispensible For Understanding Patient Journeys and Optimizing Care

    Oct 1, 2017, 00:00

  • Real-World Health Care Expenditure In Hemophilia B Patients Using Standard And Extended Half-Life Recombinant Factor IX Products

    Oct 1, 2017, 00:00

  • Impact Of Seasonal Infections On Overcrowding In A Paediatric Department Of A French Hospital In Marseille- A Retrospective Analysis

    Oct 1, 2017, 00:00

  • Methods for Extracting Treatment Patterns for Renal Cell Carcinoma (RCC) from Social Media (SM) Forums Using Natural Language Processing (NLP) and Machine Learning (ML)

    Oct 1, 2017, 00:00

  • Real Life Cost of Treatment and Follow-Up in Glioblastoma Multiforme (GBM) Patients Treated at the Antwerp University Hospital (UZA), Belgium

    Oct 1, 2017, 00:00

  • Constituição De Protocolos Clínicos E Diretrizes Terapêuticas Para Doenças Negligenciadas No Brasil

    Oct 1, 2017, 00:00

  • Xelox Versus Folfox No Tratamento Do Câncer Colorretal- Revisão De Estudos Farmacoeconômicos

    Oct 1, 2017, 00:00

  • Clinical Evaluation of CEA , CA125, CA19-9 and CA72-4 In Gastric Cancer Patients With Adjuvant Chemotherapy

    Oct 1, 2017, 00:00

  • Conceptual Modeling Framework for Global Functioning of Adhd Patients

    Oct 1, 2017, 00:00

  • Impacto Del Índice De Masa Corporal En La Salud Autopercibida- Resultados De La Encuesta Nacional De Salud De Chile 2016-2017

    Oct 1, 2017, 00:00

  • Impact Of Non-Randomised Drop-Out On Treatment Switching Adjustment In The Relapsing-Remitting Multiple Sclerosis Clarity Trial And The Clarity Extension Study

    Oct 1, 2017, 00:00

  • What Time Do We Dine?”- A Cultural Study To Evaluate People’s Views Of Set Meal Times Across Countries

    Oct 1, 2017, 00:00

  • Effects of Adherence to Pharmacological Secondary Prevention After Myocardial Infarction on Healthcare Expenditures

    Oct 1, 2017, 00:00

  • Fluoroquinolone-Related Adverse Events Resulting In Health Care Use And Costs- A Systematic Review

    Oct 1, 2017, 00:00

  • Payers, Politics and Pandemonium- An Insight Into The Future Uk Pricing and Market Access Environment

    Oct 1, 2017, 00:00

  • Risk Adjustments In Economic Models - What Is Their Impact On Predicted Rates?

    Oct 1, 2017, 00:00

  • DATABASE ANALYSIS OF A SUPPORT PROGRAM FOR PEDIATRIC PATIENTS USING SOMATROPIN DUE TO GROWTH HORMONE DEFICIENCY (GHD)

    Oct 1, 2017, 00:00

  • Probabilistic Sensitivity Analysis In Health Economic Models; How Many Simulations Should We Run?

    Oct 1, 2017, 00:00

  • Publication Timing and Data Utilisation in Cost-Effectiveness Analyses in Non-Small Cell Lung Cancer – A Literature Analysis on Publication Timing

    Oct 1, 2017, 00:00

  • Implementability Evaluation Of Antibiotics For Abdominal Trauma Guideline Using The Guideline Implementability Appraisal (GLIA) Tool

    Oct 1, 2017, 00:00

  • Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparins for Venous Thromboembolism Prevention Following Total HIP Replacement- Comparative Effectiveness and Medical Costs from a French Nationwide Cohort Study of Around 120,000 Patie ...

    Oct 1, 2017, 00:00

  • Maximizing The Value of Wearable By The Remote Collection And Analysis Of Raw 100hz Data

    Oct 1, 2017, 00:00

  • A Retrospective Study On The Antiretroviral Drug Dispensing And Adherence Of The Hungarian HIV Infected Population

    Oct 1, 2017, 00:00

  • Microbiological, Chemical Analysis and Comparison of Public Bath Waters in Baranya County Between 2010-2016

    Oct 1, 2017, 00:00

  • A Cost-Utility Analysis Of Raasi Enabling-Patiromer In Patients With Hyperkalemia

    Oct 1, 2017, 00:00

  • Epidemiology of Physician-Diagnosed Neuropathic Pain in Brazil

    Oct 1, 2017, 00:00

  • Community Pharmacists’ Interest In And Attitude To Pharmacy Practice Research In Ethiopia- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Relation of QLQ-C30 and QLQ-CR29 Health Related Quality of Life Scales and Biochemical Indicators of Nutritional Status

    Oct 1, 2017, 00:00

  • From Evaluation To Optimization- Using A Meta-Model To Maximize The Benefits Of Colorectal Screening Accounting For Capacity Constraints

    Oct 1, 2017, 00:00

  • Creating Order In Chaos - The Impact Of Brexit On The Regulatory Environment In Europe And The United Kingdom

    Oct 1, 2017, 00:00

  • Are PR Approval Of Orphan Drugs (ODS) In Spain?

    Oct 1, 2017, 00:00

  • Phase I/II Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukemia

    Oct 1, 2017, 00:00

  • Second-Line Therapy In Patients with Locally Advanced or Metastatic Urothelial Cancer- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • A Discrete Event Simulation Model For Renal Cell Carcinoma For Use In A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Urban Breast Cancer Screening Programme In China

    Oct 1, 2017, 00:00

  • Análisis Del Costo De La Atención Del Parto En Medellín

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Treatment with Ultibro Breezhaler® Versus Seretide Diskus® 50/500 Μg for Moderate to Very Severe COPD Patients

    Oct 1, 2017, 00:00

  • Epidemiology of Multiple Sclerosis- Literature Review for Prevalence and Trend Over Time in 5 European Countries and Canada

    Oct 1, 2017, 00:00

  • AVALIAÇÃO ECONÔMICA DE TECNOLOGIAS NA ÁREA DE NUTRIÇÃO- APLICAÇÕES E LIMITAÇÕES PARA O CONTEXTO BRASILEIRO

    Oct 1, 2017, 00:00

  • Societal Costs of Er+/Her2- Advanced or Metastatic Breast Cancer in Post-Menopausal Women in The United Kingdom

    Oct 1, 2017, 00:00

  • IQWIG´S GENERAL METHODS 5.0 - WHAT´S NEW?

    Oct 1, 2017, 00:00

  • Analysis Of Hospital Episode Statistics To Identify Hopsital Resource Use Due To Skin Cancer In Ireland

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Dexmedetomidine Versus Propofol Or Midazolam Sedation In Mechanical Ventilated Icu Patients In Spain

    Oct 1, 2017, 00:00

  • Do we Know Enough Yet? A Cumulative Cost-Effectiveness Analysis of Mechanical Thrombectomy

    Oct 1, 2017, 00:00

  • Navigating The Road To Reimbursement And Optimizing Uptake For Oncology Agents In The EU5- Payer And Prescriber Perspectives On The Power Of Pivotal Trial Design

    Oct 1, 2017, 00:00

  • Patients’ Priorities for Oral Anticoagulation Therapy in Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Quality-Adjusted Life Years (QALYS) for Inotuzumab Ozogamicin Versus Investigators Choice (IC) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia (R/R B-ALL)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Three European Countries Using 28-Month Overall Survival from Checkmate 067

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Sacubitril/Valsartan Compared With Standard Acei Therapies For Heart Failure Patients With Reduced Ejection Fraction In Taiwan

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Sacubitril/Valsartan Introduction For Heart Failure Treatment From The French Hospital Perspective

    Oct 1, 2017, 00:00

  • Brazilian Public Healthcare System Actions to Care For Children With Microcephaly

    Oct 1, 2017, 00:00

  • Patient Care Pathway for Post-Stroke Spasticity and Bont Management in French Hospitals Through the Prism of PMSI Data

    Oct 1, 2017, 00:00

  • Cost Associated with Ballon-Expandable Valve vs Self-Expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement

    Oct 1, 2017, 00:00

  • Statistical Methods for Critical Care Outcomes

    Oct 1, 2017, 00:00

  • Evaluating The Cost-Utility Of Immunosuppressive Regimens In Liver Transplant Recipients In Canada

    Oct 1, 2017, 00:00

  • Análise De Impacto Orçamentário Do Crizotinibe No Tratamento Do Câncer De Pulmão Não Pequenas Células Avançado Alk-Positivo Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

    Oct 1, 2017, 00:00

  • Remote Therapy Management Of Patients On Automated Peritoneal Dialysis Demonstrates Cost Savings In Germany And Italy

    Oct 1, 2017, 00:00

  • GROWTH FACTORS FOR THE MANAGEMENT OF DIABETIC FOOT ULCERS- MIXED TREATMENT COMPARISONS OF RANDOMIZED CONTROLLED TRIALS

    Oct 1, 2017, 00:00

  • Advanced Therapy Medicinal Products – Transformational Patient Benefits But Destined for Commercial Failure?

    Oct 1, 2017, 00:00

  • Secukinumab vs. Adalimumab for the Treatment of Psoriatic Arthritis- A Cost Per Responder Analysis at 48 Weeks from a Brazilian Perspective

    Oct 1, 2017, 00:00

  • Explaining Waiting Times for Scheduled Surgery Using A High-Dimensional Fixed Effects Model

    Oct 1, 2017, 00:00

  • Comparing the Efficacy, Safety, and Efficiency Outcomes Between Lensx Femtosecond Laser-Assisted Cataract Surgery and Phacoemulsification Cataract Surgery- A Meta-Analysis

    Oct 1, 2017, 00:00

  • Healthcare Costs of Ipilimumab in Patients with Advanced Cutaneous Melanoma in Dutch Clinical Practice

    Oct 1, 2017, 00:00

  • Gene-Therapy, The Way Forward In Europe – The Payer Perspective

    Oct 1, 2017, 00:00

  • Gasto Y Cobertura De Inmunización En Niños Menores De Un Año De Edad En Ecuador

    Oct 1, 2017, 00:00

  • Opioid Utilization And Cost Among Elderly And Non-Elderly Medicare Beneficiaries In The United States- A State-Level Comparison

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of A Multi-Gene Panel In The Context Of Reducing Adverse Drug Reactions

    Oct 1, 2017, 00:00

  • Economic Burden of Gastric Cancer in Turkey

    Oct 1, 2017, 00:00

  • Detección Temprana Del Cáncer De Pulmón

    Oct 1, 2017, 00:00

  • Prevalence And Perception Of Antibiotics Use In Balochistan

    Oct 1, 2017, 00:00

  • Visual Outcome of Cataract Surgery At Gondar University Hospital Tertiary Eye Care and Training Center, North West Ethiopia

    Oct 1, 2017, 00:00

  • Analytical Hierarchical Process for Evaluation of First Line Treatment of Metastatic HER2 Overexpressed Breast Cancer from Brazilian Health System Perspective

    Oct 1, 2017, 00:00

  • Cost of Treatment for Chronic Hepatitis C Infection at a National Tertiary-Care Referral Centre in an Asian Middle-Income Country

    Oct 1, 2017, 00:00

  • Budget Impact of Atezolizumab for The Treatment of 2nd Line Non-Small Cell Lung Cancer (NSCLC) After Failure with Platinum Containing Chemotherapy in Greece

    Oct 1, 2017, 00:00

  • Disease-Modifying Therapy Is Associated With Lower Medical Costs In Patients With Multiple Sclerosis With or Without Corticosteroid Treatment- A Us Retrospective Claims-Based Study

    Oct 1, 2017, 00:00

  • A Longitudinal Investigation Of The Relationships Between Patient-Reported Symptoms And Survival Among Patients with HR+/HER2- Metastatic Breast Cancer (MBC) Treated With Abemaciclib In The Phase 2 Monarch 1 Trial

    Oct 1, 2017, 00:00

  • The Future of Precision Medicine- What Does it Mean for Nice?

    Oct 1, 2017, 00:00

  • Health State Utilities Associated with Treatment Options for Acute Myeloid Leukemia (AML)

    Oct 1, 2017, 00:00

  • Examining Global Occurrence Of Complications Related To Peripheral Iv Catheters Using A Focused Literature Review

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Breech Version By Moxibustion Associated With Acupuncture For Women At 33 Weeks Gestation- A Modeling Approach By The Brazilian Public Health Care System Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Dolutegravir In HIV-1 Treatment-Naive Patients In Russia

    Oct 1, 2017, 00:00

  • Great Saphenous Vein Radiofrequency Ablation Versus Standard Stripping in The Management of Primary Varicose Veins- Economic Evaluation Into the Mexican Context

    Oct 1, 2017, 00:00

  • Clinical Outcome Assessments For Patients With Hemophilia

    Oct 1, 2017, 00:00

  • Comparison of the Assessments and Recommendations Issued by Brazil’s Conitec and Canada’s Cadth for Select Oncology Drugs

    Oct 1, 2017, 00:00

  • 10 Years Of Reimbursement Decisions In The Netherlands- An Overview

    Oct 1, 2017, 00:00

  • Analysis of The Budget Impact of Secukinumab use Versus Anti-Tnf Agents in Ankylosing Spondylitis Patients

    Oct 1, 2017, 00:00

  • Treatment Patterns for Adult Patients with Newly Diagnosed Focal Epilepsy in Germany

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis- A Canadian Perspective

    Oct 1, 2017, 00:00

  • Association Between Monthly Joint Replacement Volume and Patient Outcomes

    Oct 1, 2017, 00:00

  • Health Care Use Among Incident Cases of Heart Failure- A Population-Based Cohort Study from 1997 To 2010

    Oct 1, 2017, 00:00

  • Preliminary Results of Restarting Oral Anticoagulant Treatment In Patients with Non-Valvular Atrial Fibrillation Following Intracranial Hemorrhage- A Population-Based Cohort Study

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Statin Prioritisation Based on Absolute Risk Reduction For Primary Prevention of Cardiovascular Disease

    Oct 1, 2017, 00:00

  • An Evidence-Based Approach to Predict Long-Term Patient Outcomes and Key Value Drivers

    Oct 1, 2017, 00:00

  • Patients Oriented Access Scheme- Learning From The Success Of The Israeli Innovative Solution For The Escalating Drugs Prices

    Oct 1, 2017, 00:00

  • Cost Savings of Perioperative Anemia Treatment with Ferric Carboxymaltose In Colorectal Cancer Surgery Patients

    Oct 1, 2017, 00:00

  • Physiotherapeautic Methods Aimed To Improve The Cardiorespiratory State Before And After Operation In Patients With Lung Cancer

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Biosimilar Rituximab (CT-P10) For The Treatment Of Diffuse Large B-Cell And Follicular Lymphoma In The 28 EU Member States

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Quadrivalent Influenza Vaccine For National Immunization Program In South Korea

    Oct 1, 2017, 00:00

  • Secukinumab As A More Efficient Alternative For The Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis Versus Adalimumab And Golimumab From A Colombian Perspective

    Oct 1, 2017, 00:00

  • Factors Associated with Medication Adherence in Korean Postmenopausal Osteoporosis(PMO)- Results from PMO Outcomes Research(OR)

    Oct 1, 2017, 00:00

  • Hospital Costs Associated With Dedicated Vascular Endoprosthesis Versus Prosthetic Bypass In Popliteal Artery Aneurysm Treatment In France

    Oct 1, 2017, 00:00

  • Cost of Acute Myocardial Infarction in Colombia (2014)

    Oct 1, 2017, 00:00

  • Review Of Models Submitted To Nice Medical Technologies Evaluation Programme To Inform A Cost Consequence Template For Use In Medical Technologies Guidance Submissions

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Thresholds- Review Of Cases Around The World

    Oct 1, 2017, 00:00

  • Assessing the Burden of Chronic Heart Failure on Caregivers of Patients in Colombia

    Oct 1, 2017, 00:00

  • Attitudes Towards Generic Substitution In Greece

    Oct 1, 2017, 00:00

  • Impacto Económico Directo Derivado De La Atención De Pacientes Traumatizados En UN Hospital De México

    Oct 1, 2017, 00:00

  • Economic Impact Of Floseal In Cardiac Surgery From The Perspective Of The Mexican Institute Of Social Security (IMSS)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Midostaurin (MIDO) with Standard Chemotherapy (SOC) for Acute Myeloid Leukemia (AML) in the United Kingdom (UK)

    Oct 1, 2017, 00:00

  • Secukinumab Provides Higher Symptomatic Improvement Versus Adalimumab in Psoriatic Arthritis- Comparative Effectiveness Up to 48 Weeks Assessed by two Matching-Adjusted indirect Comparisons

    Oct 1, 2017, 00:00

  • Maintaining The Belt And Road – The Impact of 'Brexit' on UK Market Access

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Apixaban In Prevention of Stroke And Systemic Embolism In The Czech Republic

    Oct 1, 2017, 00:00

  • Patient Experience Assessments in Advanced Gastric, Esophageal, and Gastroesophageal Junction Cancer Studies

    Oct 1, 2017, 00:00

  • Stakeholder Perspectives On The Integration Of Patient Preferences In The Medical Product Life Cycle- A Multimethod Approach

    Oct 1, 2017, 00:00

  • A Model-Based Meta-Analysis For The Effect of Metformin On Hba1c Levels In Patients With Type-2 Diabetes Mellitus

    Oct 1, 2017, 00:00

  • Pricing Pressures And Market Access Outcomes Of Advanced Therapy Medicinal Products (Atmps) In The Eu5

    Oct 1, 2017, 00:00

  • Clinical Characteristics Of Patients With Chronic Hepatitis C Infection At Initial Presentation To Tertiary Care In An Asian Middle-Income Country

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Levetiracetam for Patients With Juvenile Myoclonic Epilepsy- A Modeling Approach By The Brazilian Public Health Care System Perspective

    Oct 1, 2017, 00:00

  • Systematic Review Of Economic Evaluation Studies For Dengue Vaccine- How Valid Are The Results?

    Oct 1, 2017, 00:00

  • The Real-World Impact Of Mild To Moderate Hypoglycemic Events In Portugal – Results From The Hipos-Pharma Study

    Oct 1, 2017, 00:00

  • Reliability And Validity Of The Mobility Section Of The Prosthesis Evaluation Questionnaire And Its Modified Version. Do They Measure The Same Construct?

    Oct 1, 2017, 00:00

  • Systematic Review of The Cost-Effectiveness of Medicines For The Treatment of Idiopathic Pulmonary Fibrosis

    Oct 1, 2017, 00:00

  • Reimbursed Drugs with Alternative Payment Model in Turkey

    Oct 1, 2017, 00:00

  • The Association Between Buprenorphine/Naloxone and All-Cause Mortality in the United Kingdom (UK)- An Interim Report

    Oct 1, 2017, 00:00

  • The Potential Value Of Real-World Evidence Along With Trial Efficacy To Estimate Effectiveness Of Novel Treatments In Real-World Setting; An Application With Overall Survival In Two Oncology Indications

    Oct 1, 2017, 00:00

  • Price Comparison Of New Drugs In Japan, Eu And Us

    Oct 1, 2017, 00:00

  • Trends In Emerging Non-Hta Drug Value Assessment Frameworks

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life after Major Lower Extremity Amputation Due to Musculoskeletal Tumors

    Oct 1, 2017, 00:00

  • Off-Label Drug Use In Hospitalized Children- A Prospective Observational Study At Gondar University Referral Hospital, Northwestern Ethiopia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Evaluation of a Care Bundle Intervention for Preventing Falls Among Italian Aged Inpatients in a Stepped-Wedge Cluster Randomized Controlled Trial

    Oct 1, 2017, 00:00

  • The Situation and Importance of Peritoneal Dialysis In Renal Failure- Economic Analysis

    Oct 1, 2017, 00:00

  • Safety of A Specific First Line Antiretroviral Regimen- A Review

    Oct 1, 2017, 00:00

  • Secukinumab vs Adalimumab for The Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis at 52 Weeks from A Brazilian Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Incobotulinumtoxin-A In The Longer-Term Management of Post-Stroke Spasticity of The Upper Limb

    Oct 1, 2017, 00:00

  • Does The Study Population And The Use Of Proxy Respondent Have An Effect On The Latent Quality Of Life Constructs Measured By The CHU9D And The Pedsqltm 4.0? An Exploratory Factor Analysis

    Oct 1, 2017, 00:00

  • Patterns In Working Days Lost By Parents Of Children Newly-Diagnosed With Type 1 Diabetes (T1D)

    Oct 1, 2017, 00:00

  • Evaluation of The Clinical Effectiveness of Axitinib, Cabozantinib, Everolimus, Nivolumab, Sunitinib And Best Supportive Care (BSC) In Previously Treated Advanced or Metastatic Renal Cell Carcinoma (AMRCC)- A Systematic Review And Mixed-Tre ...

    Oct 1, 2017, 00:00

  • Sensor Augmented Pum vs Multiple Daily Injections in Very Uncontrolled Diabetes Patients- Cost Model for Hypoglycemic Events, Imss Perspective

    Oct 1, 2017, 00:00

  • Analysis Of Health-Related Quality Of Life (HRQOL), And Costs Of Treatment In Chronic Myelogenic Leukemia (CML) In Bulgaria

    Oct 1, 2017, 00:00

  • Time Restricted Decisions In German Benefit Assessments – A Success Story?

    Oct 1, 2017, 00:00

  • Cost Effective Analysis Of Pharmaceutical Care In Management Of Patients With Stage Iii Hypertension- An Indian Pharmacists Experience

    Oct 1, 2017, 00:00

  • Impact of a Community Pharmacy-Based Information Program on Type 2 Diabetic Patients’ Adheren Iphodia, a Cluster Randomized Study VS Usual Practice - 12 Month Final Results

    Oct 1, 2017, 00:00

  • Landscape Of Reported Drug Shortages In European Countries

    Oct 1, 2017, 00:00

  • Comparing Costs and Outcomes Between Coblation Technology And Mechanical Debridement In The Treatment of Knee Cartilage Lesions- A Cost-Effectiveness Analysis From A Us Payer Perspective

    Oct 1, 2017, 00:00

  • Assessment Of Hypertension Patients’ Adherence In Bulgaria – Pilot Study

    Oct 1, 2017, 00:00

  • The Value Of Real-World Evidence To Support Value-Based Decision-Making- Examples For Vedolizumab In Inflammatory Bowel Disease

    Oct 1, 2017, 00:00

  • Examination Of Adherency Of High-Risk Pregnant Women With Gestational Diabetes Mellitus Care Especially With Respect To Diet And Physical Activity

    Oct 1, 2017, 00:00

  • Socio-Ecological Contextual Factors Associated with Hypertension Medication and Control Among the Elderly in Three Middle-Income Countries (Albania, Brazil, and Colombia)

    Oct 1, 2017, 00:00

  • Treatment Patterns and Satisfaction For Rheumatoid Arthritis Patients In Latin America Undergoing Advanced Therapy

    Oct 1, 2017, 00:00

  • Determinantes Dos Custos Dos Processos Judiciais De Medicamentos Em Um Município Da Região Centro-Oeste Do Brasil

    Oct 1, 2017, 00:00

  • Cataract Prevalence Estimation and Financial Requirements for Surgery Unmet Needs in Mexico- A Secondary Sources Analysis

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Duragraft As A Vein Graft Treatment In Coronary Artery Bypass Grafting In Turkey

    Oct 1, 2017, 00:00

  • An Economic Model To Support Decisions on The Adoption of Multivalent Vaccination Against Infectious Causes of Reproductive Disorders in Brazilian Cow-Calf Beef Herds Using Artificial Insemination

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis Of Increasing Peritoneal Dialysis (PD) In Adults Experiencing Unplanned Start Dialisys (Urgent Start) In Brazil

    Oct 1, 2017, 00:00

  • Prescription Writing Errors Detection by Pharmacist in A Pediatric Ward

    Oct 1, 2017, 00:00

  • A Modified Time Trade-Off Experiment In EQ-5D-3L Valuation With Fuzzy Health States Utilities

    Oct 1, 2017, 00:00

  • Evaluating Access To Treatment- A Comparison of The Expected Number of Patients with Metastatic Colorectal Cancer (Mcrc) To Those Effectively Treated in The Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Costo-Efectividad De La Cirugía Bariátrica En Colombia

    Oct 1, 2017, 00:00

  • Survival Effect, Demand Effect And Policy Effect As Drivers For Pricing Of Innovatives Anticancer Drugs

    Oct 1, 2017, 00:00

  • Estimating the Value of Patient Engagement Outcomes in Precision Medicine to Eliminate Health Disparities in US American Indian Tribal Communities- Discriminant Analysis

    Oct 1, 2017, 00:00

  • Health-Related Quality Of Life And Pharmacotherapy Costs Study For Patients With Rare Endocrine Diseases In Bulgaria – A Pilot Study

    Oct 1, 2017, 00:00

  • Evaluating Matching-Adjusted Indirect Comparison and Simulated Treatment Comparison Techniques- Impact on Health-Related Quality of Life of Focussed Ultrasound Thalamotomy and Other Interventions for the Treatment of Medication-Refractory E ...

    Oct 1, 2017, 00:00

  • A Multicenter, Observational Study To Evaluate Comorbidities In Patients Above 50 Years Of Age – Aging Positive- Characterization Of The Healthcare Resource Use

    Oct 1, 2017, 00:00

  • Nice and single? Recommendation Rates Of Oncology Therapies Approved On Clinical Trial Packages Lacking Comparative Phase 3 Data

    Oct 1, 2017, 00:00

  • Análise De Impacto Orçamentário Do Axitinibe Na Segunda Linha De Tratamento Do Carcinoma De Células Renais Metastático Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Ribociclib Plus Letrozole Versus Palbociclib Plus Letrozole for The Treatment of Post-Menopausal Women with Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced or Metasta ...

    Oct 1, 2017, 00:00

  • Budgetary Impact Analysis of the Nutritional Home Care Service

    Oct 1, 2017, 00:00

  • But Will They Trade Health? Developing An Economic Value Framework for Oncology

    Oct 1, 2017, 00:00

  • Adequacy of Glycemic Control in Greek Patients with Type 2 Diabetes Mellitus Treated with Metformin Monotherapy at the Maximum Tolerated Dose- The Reload Study

    Oct 1, 2017, 00:00

  • Dispensing Patterns of Anti-Migraine Agents with the Focus On Seasonal Variations In Prescribing

    Oct 1, 2017, 00:00

  • Type of Ancestral Native Plants Used as Intestinal Antiparasitic in Indigenous Communities- The Evanes Project

    Oct 1, 2017, 00:00

  • Cost-Effectiveness And Impact Of New Innovative Treatments On Prognosis Of Melanoma And Ovarian Cancer For Australian Patients

    Oct 1, 2017, 00:00

  • Initiatives That Impact Pricing And Reimbursement of Orphan (AND ULTRA ORPHAN) Drugs- Review of European Trends

    Oct 1, 2017, 00:00

  • The Use Of Intra-Class Correlation Coefficients To Assess Test-Retest Reliabilities In Psychometric Evaluations Of Patient Reported Outcome Measures

    Oct 1, 2017, 00:00

  • Identifying Patients With Lupus Nephritis in the United Kingdom (Uk) Clinical Practice Research Datalink (Cprd)

    Oct 1, 2017, 00:00

  • The Dynamics of Child Mental Health Care

    Oct 1, 2017, 00:00

  • Economic and Clinical Impact of Serum-Derived Bovine Immunoglobulin / Protein Isolate (SBI) in the Management of Chronic Diarrhea in Inflammatory Bowel Disease (IBD)

    Oct 1, 2017, 00:00

  • Interrogating Social Media Sources to Gain Insight on Opioid-Induced Constipation Symptoms as Reported By Patients

    Oct 1, 2017, 00:00

  • Burn Care Outside Burn Centers In Germany; Results From An Analysis of Hospital Quality Reports

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Manufacturer Fees for Htas- Are They Promoting or Hindering Innovation?

    Oct 1, 2017, 00:00

  • Risk Factors Associated With Tuberculosis In Punjab, Pakistan

    Oct 1, 2017, 00:00

  • Treatment Cost Comparison of Pirfenidone Versus Nintedanib on The Treatment of Idiopathic Pulmonary Fibrosis

    Oct 1, 2017, 00:00

  • Availability of Health Economic Model Inputs In Japan- A Targeted Literature Review

    Oct 1, 2017, 00:00

  • Budget Impact of Ribociclib Plus Letrozole For The Treatment of Post-Menopausal Women With Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2- Negative (HER2-) Advanced or Metastatic Breast Cancer From A US Private Th ...

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Cobicistat-Boosted Darunavir In Hiv-Infected Patients In Mexico

    Oct 1, 2017, 00:00

  • Costo Medico Directo Atribuible Al Tratamiento De Pacientes Con Neoplasia Intraepitelial Cervical (CIN) 2 Morfológico E Impacto Económico Del Diagnóstico Diferencial Con Biomarcador P16 En Una Institución Privada De La Ciudad De Buenos Aire ...

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Coblation Technology VS. Mechanical Debridement With A Shaver In The Treatment Of Knee Cartilage Lesions- A Spanish Payer Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectivenes Analysis of Anti-Tnf Use Compared To Dmards in The Fatal and Nonfatal Acute Coronary Ischemic Event

    Oct 1, 2017, 00:00

  • Orphan Drugs In The Uk, Do They Meet The Nice Highly Specialised Technology Threshold?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Reperfusion Strategies For St-Elevation Myocardial Infarction. Real-World Data From The Stent For Life Initiative In Italy

    Oct 1, 2017, 00:00

  • A Multi-Centre Retrospective Study To Describe The Impact on Healthcare Resource Use And Real World Effectiveness of Golimumab In Ankylosing Spondylitis (AS) In UK Clinical Practice

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Haploidentical Vs Matched Unrelated Allogeneic Hematopoietic Stem Cells Transplantation in Patients Older Than 55 Years

    Oct 1, 2017, 00:00

  • Pharmaceutical Care Workload And Workforce Requirement At Ministry Of Health Primary Care Centers During Ten Years Mass Gathering Hajj (2006-2015) In Makah Regions, Saudi Arabia

    Oct 1, 2017, 00:00

  • Impact of End-Stage Renal Disease on Health Economic Outcomes of Hyperkalaemia Management In Patients With Chronic Kidney Disease

    Oct 1, 2017, 00:00

  • Metodology To Assess Pricing And Reimburesment (PR) Potential In Central And European (CEE) Countries

    Oct 1, 2017, 00:00

  • Dyslipidemia Treatment And CVD Risk In Adult Russians Who Reported Dyslipidemia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Bezlotoxumab + Standard Of Care (SOC) Versus Placebo + Soc For The Prevention Of Recurrent Clostridium Difficile Infection In The United Kingdom

    Oct 1, 2017, 00:00

  • Evaluating The Importance Of Realistically Simulating Risk Factor Progression Over Time- A Health Economic Modeling Analysis In Type 1 Diabetes

    Oct 1, 2017, 00:00

  • Treatment Persistence In Psoriasis Patients Initiated on Apremilast, Oral Systemics, or Biologic Therapies

    Oct 1, 2017, 00:00

  • Psoriatic Arthritis Limits Patients’ Ability to Contribute to Society As Part of the Workfor Results from A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Key Drivers In Health Technology Assessment By Analysing The Level Of Improvement In Actual Benefit In Solid Tumor Oncology Drugs

    Oct 1, 2017, 00:00

  • Switching of Biological Drugs in Rheumatoid Arthritis- A Cohort of Users from the Brazilian Public Health System

    Oct 1, 2017, 00:00

  • A Literature Review of Health Economic Assessments, Health Care Resource Utilization (HCRU), and Health Related Quality-of-Life (HRQOL) in Patients with Gastric Cancer (GC)

    Oct 1, 2017, 00:00

  • Health Insurance Cost of Affective Disorders In Hungary- A Cost of Illness Study

    Oct 1, 2017, 00:00

  • Quantifying the Trade-off Between Improved Glycemic Control and Severe Hypoglycemia Risk in Patients with Type 1 Diabetes- A Health Economic Analysis in the Uk

    Oct 1, 2017, 00:00

  • Validity and Interpretation of A Skin Pain Numeric Rating Scale Among Adults and Adolescents With Atopic Dermatitis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of 10% Intravenous Immunoglobulin Compared With Plasma Exchange In Treatment Of Children With Guillain–Barré Syndrome In Russia

    Oct 1, 2017, 00:00

  • Creating Individualized HBA1C Targets Using Predictive Modeling

    Oct 1, 2017, 00:00

  • The Clinical and Cost-Effectiveness of Different Maternal Syphilis Screening Strategies in Brazil

    Oct 1, 2017, 00:00

  • Access To Medicines For Rare Diseases In Australia- The Current Climate For Reimbursement

    Oct 1, 2017, 00:00

  • No Evidence For An Association Between Renal Function And Bleeding Events In Patients On Coumarin Therapy- A Population-Based Study

    Oct 1, 2017, 00:00

  • Comparison of Recent Hta Appraisals of Orphan Drugs By Nice, SMC And Has In 2015-2017

    Oct 1, 2017, 00:00

  • Cambio En La Carga De Enfermedad Ajustada Por Riesgo Para Una Población Afiliada A UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Processes And Requirements For Health Economic Assessment Of Antibiotics For Hta Purposes- Time For A Paradigm Shift?

    Oct 1, 2017, 00:00

  • Exploring Concurrent Validity of The CLN2 Clinical Rating Scale- Comparison To Pedsql Using Mixed Effects Modelling And Data From A Phase 1/2 Single-Arm Trial

    Oct 1, 2017, 00:00

  • Real World Comparison of Persistence And Adherence Among Biologic Naïve Patients Initiating Apremilast or Biologics for The Treatment of Psoriasis In The United States

    Oct 1, 2017, 00:00

  • Eating Habits and Physical Exercise Practices of Beneficiaries and Non-Beneficiaries of Private Health Plans In Brazil

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden- Analysis Using 28-Month Overall Survival from Checkmate 067

    Oct 1, 2017, 00:00

  • Subcutaneous Drugs In Oncology- Make A Difference In The Treatment? Systematic Review From Different Analytical Perspectives

    Oct 1, 2017, 00:00

  • Cost-Consequence Analysis of Using Neurofarmagen In The Decision-Making Process During The Treatment of Patients With Depression In The U.S

    Oct 1, 2017, 00:00

  • Development Of A Descriptive System For Measuring Patient Experience

    Oct 1, 2017, 00:00

  • Efficacy-Based Budget Impact Analysis of Secukinumab Vs Adalimumab in the Treatment of Ankylosing Spondylitis in Finland

    Oct 1, 2017, 00:00

  • Association Between Tumour Lesion Size and Health-Related Quality of Life Outcomes in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

    Oct 1, 2017, 00:00

  • Characteristics of Psoriasis Patients In Latin America

    Oct 1, 2017, 00:00

  • The Impact of Beliefs Towards Illness and Medications on Adherence and Clinical Outcomes in Acute Coronary Syndrome Patients in Hong Kong

    Oct 1, 2017, 00:00

  • Economic Evaluation And Budget Impact Analysis Of Prothrombin Complex Concentrate (Beriplex®) For Treatment And Prophylaxis Of Bleeding In Patients Treated With Oral Anticoagulants Under Perspective Of Health Public Institutions In Mexico

    Oct 1, 2017, 00:00

  • ADC, NOT AS EASY AS 123 - The Unprecedented Example Of Trastuzumab-Emtansine In The Nice Appraisal Process

    Oct 1, 2017, 00:00

  • Costs of Managing Hypoglycaemias Among Insulin-Treated Patients with Diabetes- Results from the Hat Study in Brazil

    Oct 1, 2017, 00:00

  • Force Of Infection Of Helicobacter Pylori In Mexico- Evidence From A National Survey

    Oct 1, 2017, 00:00

  • An Innovative Solution to Achieve Cost-effectiveness and A Positive Nice Appraisal? – The Cabazitaxel Case Study

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis of Strategies for Cervical Cancer Prevention and Control in Indonesia

    Oct 1, 2017, 00:00

  • Evaluating The Clinical Effectiveness of Trastuzumab Emtansine (T-DM1) Versus All Other Treatments For Previously Treated, Unresectable, HER2-Positive Metastatic Breast Cancer (MBC)- A Mixed Treatment Comparison (MTC)

    Oct 1, 2017, 00:00

  • Estimation of the Additional Budget Saving Potential Due to the Rapid Adoption of An Etanercept Biosimilar (SB4) for the Treatment of Approved Adult Etanercept Indications in Spain

    Oct 1, 2017, 00:00

  • Budget Impact Model of Cobimetinib in Combination with Vemurafenib For Previously Untreated Braf V600-Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Universal Neonatal Hearing Screening With Otoacoustic Emissions And/Or Automated Auditory Brainstem Response, For The Detection Of Bilateral Congenital Hearing Loss And Early Treatment, In Newborns Without Risk Factors ...

    Oct 1, 2017, 00:00

  • Evaluation of Anti-Asthmatic Potential of Artemisia Pallens Walls In Ovalbumin-Induced Airway Hyperresponsiveness in Laboratory Rats

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Ulinastatin for Patients Undergoing Hepatectomy- A Discrete Event Simulation Model

    Oct 1, 2017, 00:00

  • Time To Clinically Meaningful Worsening In Hepatocellular Carcinoma Patients Treated With Lenvatinib or Sorafenib

    Oct 1, 2017, 00:00

  • A Saúde Do Trabalhador Em Questão- Análise Do Absenteísmo E O Perfil Dos Atestados Médicos Em Um Hospital De Grande Porte No Ceará

    Oct 1, 2017, 00:00

  • Assessing The Economic Impact Of The Introduction Of Daclatasvir In Combination With Asunaprevir For The Treatment Of Chronic Hepatitis C In China

    Oct 1, 2017, 00:00

  • Risk Factors of Asthma and Their Role in Triggering The Asthmatic Attack

    Oct 1, 2017, 00:00

  • Effectiveness and Persistence of The First Tumor Necrosis Factor Inhibitor In Portuguese Psoriatic Arthritis Patients

    Oct 1, 2017, 00:00

  • The Impact of Missed Treatment Opportunities on Outcomes In Hospitalised Heart Failure Patients- Modelling Analysis Based on The National Heart Failure Audit

    Oct 1, 2017, 00:00

  • Improving Transparency In Health Technology Assessment

    Oct 1, 2017, 00:00

  • Exploring Factors Explaining Treatment Acceptance in Patients Suffering from a Chronic Disease

    Oct 1, 2017, 00:00

  • A Budget Impact Model of The Addition of Telotristat Ethyl Treatment In Patients With Uncontrolled Carcinoid Syndrome

    Oct 1, 2017, 00:00

  • Surgical Treatment Outcome of Lumbar Disc Herniation (LDH) In Different Ages

    Oct 1, 2017, 00:00

  • Adherence Issues in Multiple Sclerosis Treatment- How Can Acceptance Measurement Help Understanding Patients’ Concerns and Working on Solutions?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Peginterferon Beta-1a Vs. First-Line Injectable Disease-Modifying Therapies For The Treatment of Relapsing-Remitting Multiple Sclerosis In Spain

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Apremilast for The Treatment of Moderate To Severe Psoriasis In Greece

    Oct 1, 2017, 00:00

  • Pricing Pantoprazole In Gree A Tale Of Distortion

    Oct 1, 2017, 00:00

  • Dose Increase Beyond Labelled Dose of Biologic Treatments In Psoriasis Patients- A Real-World Study In Sweden

    Oct 1, 2017, 00:00

  • Relative Value of Evidem Mcda Framework for Reflective Drug Evaluation Among Therapeutic Positioning Report Evaluators From The Spanish Agency of Medicines

    Oct 1, 2017, 00:00

  • Capturing Patient Perspectives In The Evaluation Of Medical Devices- The Case Of Central Venous Access Devices In Chemotherapy

    Oct 1, 2017, 00:00

  • Intravenous Iron Treatments For Iron Deficiency Anemia In Inflammatory Bowel Disease- A Budget Impact Analysis Of Iron Isomaltoside 1000 In The UK

    Oct 1, 2017, 00:00

  • Disclosing Traditional CM) Use to the Health Care Providers- A Qualitative Study Among Thalassemia Patients in Malaysia

    Oct 1, 2017, 00:00

  • Real-World Resource Use And Costs of Carcinoid Heart Disease In Patients With Neuroendocrine Tumors- A Retrospective Swedish Study

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure With Reduced Ejection Fraction In Korea

    Oct 1, 2017, 00:00

  • Uncertainty In Selecting Survival Models For Cost Effectiveness Analyses

    Oct 1, 2017, 00:00

  • A Systematic Literature Review Of The Societal Costs And Consequences Of Heroin Addiction

    Oct 1, 2017, 00:00

  • When The Price Is Right- When, In Practice, Are Confidential Discounts Introduced In The Nice Process?

    Oct 1, 2017, 00:00

  • Early Scientific Advice At Cadth – Options and Recommendations For Future Development

    Oct 1, 2017, 00:00

  • Can Bayesian Methodology Predict Long-Term Effectiveness Rather Than Efficacy? An Application with Overall Survival in Two Oncology Indications

    Oct 1, 2017, 00:00

  • Structured Education Program For Injection Technique - Budget Impact Model

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Tapentadol Prolonged Release Versus Oxycodone Controlled Release In The First-Line Treatment of Moderate To Severe Chronic Pain Under The Perspective of The Colombian Subsidized Public Healthcare System

    Oct 1, 2017, 00:00

  • Guidance for Developing A Study Protocol of A Causal Comparative Effectiveness Analysis in “Big Data”- The Case of When To Start Statin Treatment

    Oct 1, 2017, 00:00

  • Biosimilar Uptake In The Uk- An Evolving Story?

    Oct 1, 2017, 00:00

  • Intestinal Parasitic Disease And Hygienic Conditions In Children- Diagnostic Evaluation For Prevention

    Oct 1, 2017, 00:00

  • Reliability And Validity Of Two Proxy Versions Of EQ-5D-5L In Japan

    Oct 1, 2017, 00:00

  • Comparative Evaluation of the Efficacy of Herbal and Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Dysmenorrhea in Women With Female Reproductive Tract Congenital Anomalies

    Oct 1, 2017, 00:00

  • Cognitive Debriefing Of The Dmd-Specific Measures Of Physical Functioning – Caregiver Questionnaire

    Oct 1, 2017, 00:00

  • Estudio De Costo-Efectividad E Impacto Presupuestal De Denosumab vs. Ácido Zoledrónico Para El Manejo De Metástasis Óseas En Pacientes Con Cáncer De Próstata En Colombia

    Oct 1, 2017, 00:00

  • Secukinumab is Dominant Vs. TNF-Inhibitors in the Treatment of Active Ankylosing Spondylitis- Results from a Turkish Cost-Effectiveness Model

    Oct 1, 2017, 00:00

  • The Clinical and Cost Effectiveness of Dasatinib Versus Nilotinib for The First and Second Line Treatment of People with Chronic Myeloid Leukaemia

    Oct 1, 2017, 00:00

  • Parametric Modelling of Migraine Day Frequency In Migraine Prevention- A Case Study Of Erenumab Clinical Trial Data

    Oct 1, 2017, 00:00

  • Burden of Genital Warts In Ecuador- An Observational Study

    Oct 1, 2017, 00:00

  • A Systematic Review To Evaluate The Association Between Medication Adherence And Personality Traits

    Oct 1, 2017, 00:00

  • Newest Target Therapy And Immunotherapy for the Treatment of Advanced Melanoma- Patterns of Adoption By the Private Health Care Sector in Brazil

    Oct 1, 2017, 00:00

  • In What Sequence Do Companies Submit Health Technology Appraisal (HTA) Dossiers In The UK And Ireland, And In What Sequence Are They Published?

    Oct 1, 2017, 00:00

  • Disease-Related Cost Burden In Patients Undergoing Sinus Surgery For Chronic Rhinosinusitis- A Claims-Based Analysis

    Oct 1, 2017, 00:00

  • Long-Term Impact of Grass-Pollen (GP) Sublingual Immunotherapy Tablet (SLIT) on Allergic Rhinitis (AR) and on Allergic Asthma (AA) Onset and Progression

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Mexico

    Oct 1, 2017, 00:00

  • Clinical and Patient Reported Outcomes In Psoriatic Arthritis- A Narrative Review of The Literature

    Oct 1, 2017, 00:00

  • Palliative Care Services In Romania- Analysis Of Utilization, Funding And Coverage

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients In Brazil

    Oct 1, 2017, 00:00

  • Access to New Treatments For Chronic Hepatitis C in Four Latin American Countries

    Oct 1, 2017, 00:00

  • Modeling Covariate-Adjusted Survival for Economic Evaluations in Oncology

    Oct 1, 2017, 00:00

  • What Do The Single Technology Appraisals of The Past Tell US About Fast-Tracking The Most Cost-Effective New Technologies In The Future?

    Oct 1, 2017, 00:00

  • Assessing The Implications Of The Nice Budget Impact Test- How Many Oncology Regimens Will Be Affected And What Will Be The Impact On Patient Outcomes?

    Oct 1, 2017, 00:00

  • Assessing Cost-Effectiveness And Key Value Drivers of Adjuvant Triglyceride Lowering Therapy In Management of Patients with A Rare Genetic Syndrome

    Oct 1, 2017, 00:00

  • Treatment Sequencing for Patients With Multiple Myeloma with at Least One Prior Line- Comparing Progression-Free Survival and Costs Under a Private Payer Perspective

    Oct 1, 2017, 00:00

  • Enhancement Program For Couples Adjustment To Failed Assisted Reproductive Technology

    Oct 1, 2017, 00:00

  • Effect of Pharmacist Care on Medication Adherence and Cardiovascular Outcomes Among Patients Post-Acute Coronary Syndrome- A Systematic Review

    Oct 1, 2017, 00:00

  • Using Electronic Health Records As A Real World Comparator- A Case Study In A Single Arm Oncology Trial

    Oct 1, 2017, 00:00

  • Treatment Cost of Hepatocellular Carcinoma from The Health Insurance’s Perspective in Viet Nam

    Oct 1, 2017, 00:00

  • Cost And Operational Efficiency Comparison Of An Integrated VS. A Multi-Step System For Extracorporeal Photopheresis In Germany

    Oct 1, 2017, 00:00

  • Market Access and Its Impact on Decision Making In Spain. An Example In Acute Myeloid Leukemia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Surgical Approaches Total HIP Arthroplasty

    Oct 1, 2017, 00:00

  • Review Of Reimbursement Decision Drivers For Rare Cancer Therapies Across EU5 Markets

    Oct 1, 2017, 00:00

  • Burden of Disease for Psoriasis In Argentina, Brazil, Colombia and Mexico

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Fidaxomicin Versus Vancomycin And Metronidazole In Patients With Clostridium Difficile Infection In Spain

    Oct 1, 2017, 00:00

  • Abaloparatide For Risk Reduction of Nonvertebral And Vertebral Fractures In Postmenopausal Women With Osteoporosis- A Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Biologic Uptake Trends In Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Open Tibial Fractures With Segmental Defects- A U.S. Retrospective Database Analysis Examining 12-Month Post-Operative Patient Outcomes And Costs

    Oct 1, 2017, 00:00

  • Burden Of Diabetes Mellitus In Patients With Acromegaly Treated With Second-Line Pharmacotherapy In Spain

    Oct 1, 2017, 00:00

  • Repellent And Larvicidal Activity Of Thai Medicinal Plants Against Mosquitoes- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62 (current)
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • »